Yahoo

Study Finds the Corus(R) CAD Gene Expression Blood Test Influenced Primary Care Decision-Making in the Assessment of Patients With Suspected Obstructive Coronary Artery Disease

PALO ALTO, CA--(Marketwired - Mar 10, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of the IMPACT-PCP (Investigation ...
Nature

Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI

The true incidence of obstructive coronary artery disease (CAD) among patients undergoing transcatheter aortic valve implantation (TAVI) is not known Assessment of CAD using angiography only can ...
FiercePharma

CardioDx’s Corus CAD Gene Expression Test Performs Equally Well in Both Women and Men for the Assessment of Obstructive Coronary Artery Disease, Study Shows

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced online publication of a study in the The paper, titled “A Gender Specific Blood-Based Gene Expression ...